AR Asset Management’s AbbVie ABBV Stock Holding History

AR Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.84M	Buy	45,226 +2,266	+5%	+$503K	1.9%	15
2025 Q4	$9.82M	Hold	42,960	–	–	2.01%	14
2025 Q3	$9.95M	Hold	42,960	–	–	2.1%	14
2025 Q2	$7.97M	Hold	42,960	–	–	1.77%	15
2025 Q1	$9M	Hold	42,960	–	–	2.04%	13
2024 Q4	$7.63M	Sell	42,960 -240	-0.6%	-$44.1K	1.73%	16
2024 Q3	$8.53M	Hold	43,200	–	–	1.9%	15
2024 Q2	$7.41M	Hold	43,200	–	–	1.79%	15
2024 Q1	$7.87M	Hold	43,200	–	–	1.92%	14
2023 Q4	$6.7M	Hold	43,200	–	–	1.76%	17
2023 Q3	$6.44M	Sell	43,200 -300	-0.7%	-$44K	1.81%	17
2023 Q2	$5.86M	Hold	43,500	–	–	1.57%	19
2023 Q1	$6.93M	Hold	43,500	–	–	1.87%	15
2022 Q4	$7.03M	Hold	43,500	–	–	2%	15
2022 Q3	$5.84M	Hold	43,500	–	–	1.75%	16
2022 Q2	$6.66M	Hold	43,500	–	–	1.88%	15
2022 Q1	$7.05M	Hold	43,500	–	–	1.78%	17
2021 Q4	$5.89M	Hold	43,500	–	–	1.5%	22
2021 Q3	$4.69M	Buy	43,500 +5,300	+14%	+$606K	1.31%	25
2021 Q2	$4.3M	Hold	38,200	–	–	1.2%	27
2021 Q1	$4.13M	Hold	38,200	–	–	1.24%	25
2020 Q4	$4.09M	Hold	38,200	–	–	1.32%	22
2020 Q3	$3.35M	Hold	38,200	–	–	1.18%	29
2020 Q2	$3.75M	Hold	38,200	–	–	1.42%	22
2020 Q1	$2.91M	Buy	38,200 +26,000	+213%	+$2.21M	1.2%	29
2019 Q4	$1.08M	Hold	12,200	–	–	0.36%	61
2019 Q3	$924K	Hold	12,200	–	–	0.33%	68
2019 Q2	$887K	Hold	12,200	–	–	0.32%	69
2019 Q1	$983K	Hold	12,200	–	–	0.37%	62
2018 Q4	$1.13M	Hold	12,200	–	–	0.48%	50
2018 Q3	$1.15M	Hold	12,200	–	–	0.42%	55
2018 Q2	$1.13M	Hold	12,200	–	–	0.44%	53
2018 Q1	$1.16M	Hold	12,200	–	–	0.47%	51
2017 Q4	$1.18M	Hold	12,200	–	–	0.45%	50
2017 Q3	$1.08M	Hold	12,200	–	–	0.43%	55
2017 Q2	$885K	Hold	12,200	–	–	0.36%	64
2017 Q1	$795K	Hold	12,200	–	–	0.33%	68
2016 Q4	$764K	Hold	12,200	–	–	0.33%	66
2016 Q3	$769K	Hold	12,200	–	–	0.33%	72
2016 Q2	$755K	Hold	12,200	–	–	0.32%	71
2016 Q1	$697K	Hold	12,200	–	–	0.3%	70
2015 Q4	$723K	Hold	12,200	–	–	0.33%	70
2015 Q3	$664K	Hold	12,200	–	–	0.3%	75
2015 Q2	$820K	Hold	12,200	–	–	0.34%	66
2015 Q1	$714K	Hold	12,200	–	–	0.29%	73
2014 Q4	$798K	Hold	12,200	–	–	0.32%	69
2014 Q3	$705K	Buy	12,200 +3,500	+40%	+$194K	0.29%	70
2014 Q2	$491K	Hold	8,700	–	–	0.2%	85
2014 Q1	$447K	Hold	8,700	–	–	0.19%	89
2013 Q4	$459K	Hold	8,700	–	–	0.19%	85
2013 Q3	$389K	Hold	8,700	–	–	0.17%	89
2013 Q2	$360K	Buy	+8,700	New	+$380K	0.16%	91

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AR Asset Management's ABBV Position: Q1 2026 in Review

AR Asset Management increased its AbbVie (ABBV) stake by 5.3% in Q1 2026, buying an estimated $503K and bringing the position to 45,226 shares worth $9.84M. The position accounts for 1.9% of the portfolio, ranked #15.

AR Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.95M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

AR Asset Management held 45,226 shares of AbbVie worth $9.84M as of Q1 2026.
AR Asset Management bought 2,266 AbbVie shares in Q1 2026, an estimated $503K.
AbbVie made up 1.9% of AR Asset Management's portfolio in Q1 2026, its #15 holding.
AR Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
AR Asset Management's AbbVie position peaked at $9.95M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AR Asset Management's 13F filing for Q1 2026, filed 13 May 2026.